Summary

The Carbetocin market is expected to grow at a strong CAGR of around 5% during the forecast period. Carbetocin is a synthetic peptide used for the prevention and treatment of postpartum hemorrhage (PPH). PPH is a serious condition that can occur after childbirth and can lead to maternal mortality. Carbetocin works by stimulating uterine contractions, which helps to prevent excessive bleeding. The market for carbetocin is expected to grow at a significant rate due to factors such as increasing awareness about maternal health and rising expenditure in mother and childcare treatments.

Some of the major players operating in the market include Ferring B.V.; Hybio Pharmaceutical Co., Ltd.; Pfizer Inc.; Beacon Pharmaceuticals Limited; SGPharma Pvt. Ltd.; Taj Pharmaceuticals; Abbott; MANUS AKTTEVA BIOPHARMA LLP; Enomark; and Sun Pharmaceutical Industries Ltd Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst type, the generic drug segment is expected to grow at a higher CAGR during the forecast period.”
Based on type, the market is segmented into original drug and generic drug. As per our analysis, the generic drug segment is expected to grow at a higher CAGR during the forecast period. Generic drugs are cheaper and can be easily available in the market. The increasing patented drug expiration is the major reason for the fast growth of generic drugs in the carbetocin market.

“Amongst end-user, the hospitals segment held the dominant share in 2021.”
Based on the end-user, the market is segmented into hospitals, clinics, and others. As per our analysis, the hospitals held the dominant share in 2021. Carbetocin is a commonly used medication in obstetrics and is likely to be available in many hospitals worldwide, particularly those that provide maternity care. The hospitals are advancing their facilities and they have specialized departments for maternal care is the major reason for the large share of the hospital segment in the market.

“Asia Pacific is expected to grow with the highest CAGR Carbetocin market during the forecast period.”
Asia Pacific is expected to grow with the highest CAGR Carbetocin market during the forecast period due to its large population and the high birthrates in the region are major attributing factors for the market growth of the carbetocin market in the region. For instance, as per the World Bank, the average fertility rate of Indian women is 2.05 and the population of the country is continuously rising.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global carbetocin market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents